Lead Sponsor

Medical University Innsbruck

Age

21 - 90 years

Sex

ALL

Healthy Volunteers

No

•Male or female patients between 21 and 90 years of age undergoing primary coronary artery bypass grafting
•Presentation with reduced left ventricular function, defined as LVEF ≤ 40% measured by cardiac MRI
•Presentation with regional left ventricular wall motion abnormalities
•Written informed consent from the patient for participation in the study

•Significant concomitant aortic valve disease requiring surgical treatment (other than significant aortic valve disease not detected in preoperative cardiac ultrasound but detected during surgery)
•Serious radiographic contrast allergy
•Patient in cardiogenic shock or presenting with acute myocardial infarction (STEMI or NSTEMI)
•Patient with a contraindication for cardiac MRI
•History of significant ventricular arrhythmia, other than MI-associated arrhythmia
•Comorbidity reducing life expectancy to less than one year
•Presence of a ventricular thrombus
•Presence of a cardiac tumour
•Pregnancy